 |
인쇄하기
취소
|
CJ’s incrementally modified drug to be launched from next January
CJ Pharma has recently unveiled its plan to launch its incrementally modified drug (IMD) Vogmet from next January.
Last June, the Ministry of Food and Drug Safety (MFDS) approved another combination of metformin plus voglibose, a dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes, CJ said.
According to the company, Vogmet indicated as an adjunct to diet and exercise to improve g...
Last June, the Ministry of Food and Drug Safety (MFDS) approved another combination of metformin plus voglibose, a dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes, CJ said.
According to the company, Vogmet indicated as an adjunct to diet and exercise to improve g...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.